Apex Biotech Ltd, a pharmaceutical manufacturing firm co-owned by Rwandans and Bangladeshi investors, is expected to open within the next nine months, officials say.
Stakeholders are optimistic that at a time when non-communicable diseases continue to claim more lives than any other disease group, an additional pharmaceutical firm into the Rwandan market will go a long way in ensuring timely detection, prevention, and treatment and consequently reduce resultant mortality rate.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article